title: Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence?
authors.affiliation: Hospital for Children and Adolescents, University of Leipzig, Germany.
authors.forename: G M C
authors.initials: GM
authors.lastname: Flemming
authors.forename: G
authors.initials: G
authors.lastname: Tóth
authors.forename: C
authors.initials: C
authors.lastname: Gebauer
authors.forename: V
authors.initials: V
authors.lastname: Schuster
mesh_terms: D000293:Adolescent; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001171:Arthritis, Juvenile / Q000175:diagnosis / Q000188:drug therapy*; D001706:Biopsy; D002648:Child; D003113:Colonoscopy; D003424:Crohn Disease / Q000139:chemically induced* / Q000175:diagnosis; D057915:Drug Substitution; D000068800:Etanercept; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use*; D007413:Intestinal Mucosa / Q000187:drug effects / Q000473:pathology; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept